Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low-to intermediate-grade neuroendocrine tumors : results of a phase II study

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1573105975572218112
  • NII Article ID
    10030474348
  • Data Source
    • CiNii Articles

Report a problem

Back to top